These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 11861525)

  • 1. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.
    Combs TP; Wagner JA; Berger J; Doebber T; Wang WJ; Zhang BB; Tanen M; Berg AH; O'Rahilly S; Savage DB; Chatterjee K; Weiss S; Larson PJ; Gottesdiener KM; Gertz BJ; Charron MJ; Scherer PE; Moller DE
    Endocrinology; 2002 Mar; 143(3):998-1007. PubMed ID: 11861525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.
    Berg AH; Combs TP; Du X; Brownlee M; Scherer PE
    Nat Med; 2001 Aug; 7(8):947-53. PubMed ID: 11479628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.
    Moore GB; Chapman H; Holder JC; Lister CA; Piercy V; Smith SA; Clapham JC
    Biochem Biophys Res Commun; 2001 Aug; 286(4):735-41. PubMed ID: 11520059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
    Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
    Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.
    Smith U; Gogg S; Johansson A; Olausson T; Rotter V; Svalstedt B
    FASEB J; 2001 Jan; 15(1):215-220. PubMed ID: 11149909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
    Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
    Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
    Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.
    Li Y; Lazar MA
    Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
    Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
    Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
    Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
    J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
    Misra P; Chakrabarti R; Vikramadithyan RK; Bolusu G; Juluri S; Hiriyan J; Gershome C; Rajjak A; Kashireddy P; Yu S; Surapureddi S; Qi C; Zhu YJ; Rao MS; Reddy JK; Ramanujam R
    J Pharmacol Exp Ther; 2003 Aug; 306(2):763-71. PubMed ID: 12730351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes.
    Kitazawa M; Nagano M; Masumoto KH; Shigeyoshi Y; Natsume T; Hashimoto S
    Endocrinology; 2011 Jul; 152(7):2558-67. PubMed ID: 21586562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.
    Maeda N; Takahashi M; Funahashi T; Kihara S; Nishizawa H; Kishida K; Nagaretani H; Matsuda M; Komuro R; Ouchi N; Kuriyama H; Hotta K; Nakamura T; Shimomura I; Matsuzawa Y
    Diabetes; 2001 Sep; 50(9):2094-9. PubMed ID: 11522676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
    Berger JP; Petro AE; Macnaul KL; Kelly LJ; Zhang BB; Richards K; Elbrecht A; Johnson BA; Zhou G; Doebber TW; Biswas C; Parikh M; Sharma N; Tanen MR; Thompson GM; Ventre J; Adams AD; Mosley R; Surwit RS; Moller DE
    Mol Endocrinol; 2003 Apr; 17(4):662-76. PubMed ID: 12554792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
    Vikramadithyan RK; Chakrabarti R; Misra P; Premkumar M; Kumar SK; Rao CS; Ghosh A; Reddy KN; Uma C; Rajagopalan R
    Metabolism; 2000 Nov; 49(11):1417-23. PubMed ID: 11092504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
    Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
    Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.